Swissquote Bank Ltd., Switzerland’s leading online bank, announces the launch of a set of investor tools that help anticipate the impact of the French presidential election on financial markets. A key element is the Social Media Opinion Index, created in cooperation with the Social Media Lab at École polytechnique fédérale de Lausanne (EPFL).
The Index makes use of the latest advances in artificial intelligence to collect and analyze opinions about the candidates in the French election as expressed on social media networks; it allows investors to take the pulse of public online opinion about the candidates, indicating potential outcomes of the elections in real-time.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8083151-french-election-swissquote-epfl-investors/
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Leading frozen bread manufacturer and the original inventor of frozen garlic bread, Cole’s Quality Foods, Inc., innovates the frozen food category yet again with the introduction of Middles™, a stuffed bread that combines delicious, decadent, savory, salty and sweet flavors into one revolutionary snack concept.
Middles become available later this month in the freezer section at grocery, club, supermarket and convenience stores nationwide for a suggested retail price of $3.99 per 10.8-ounce box. Each box contains eight tasty bread bites.
Inspired by the much-celebrated combination of bread and cheese, Middles advances the concept by featuring the soft “middle” section of popular bakery staples, including bagel, Italian and pretzel breads. They are then stuffed with savory and sweet centers, including cheddar cheese, cream cheese, and beer cheese varieties. The result is an outrageously delicious heat-and-serve stuffed bread snack that can be made in either microwave or conventional ovens in just seven to nine minutes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8139251-coles-frozen-bread-middles/
REMBRANDT®, the original teeth whitening brand, advances the at-home whitening category with the launch of a new 1 Week Whitening Kit and 3 Day Whitening Boost Kit that provide visibly whiter smiles from the comfort of home in half the time of traditional 14-day kits.
Perfect for whitening with short notice before a big event or special occasion, the kits arrive online at Rembrandt.com this month at a suggested retail price of $24.99 and $6.99 each, respectively. The 1 Week Whitening Kit is available in-store exclusively at Walmart today and will arrive in Harmon Face Values and select Bed Bath & Beyond stores in late October.
To view the multimedia release go to:
https://www.multivu.com/players/English/8165651-rembrandt-stayput-custom-fit-whitening-strips/
TransCelerate BioPharma Inc., a non-profit organization dedicated to improving the health of people around the world by simplifying and accelerating research and development of innovative new therapies, has unveiled a new global campaign designed to help increase awareness of the growing need for clinical trial participants. The campaign, called “One Person Closer,” focuses on inspiring healthcare professionals (HCPs) to consider clinical research as a possibility for their patients, incorporate the topic into their daily practices, and have meaningful conversations with patients about opportunities to participate in clinical trials.
One Person Closer is designed to put a human face on research and development by sharing the personal stories of researchers, HCPs and patients who have contributed to clinical research and the development of medical breakthroughs. The photojournalist campaign aims to show doctors, nurses and other HCPs that they can help facilitate research that advances science and that may benefit their patients.
To view the multimedia release go to:
https://www.multivu.com/players/English/8268751-transcelerate-biopharma-one-person-closer/
As breakthroughs in cancer treatments are occurring at an ever increasing rate, The Leukemia & Lymphoma Society (LLS) is shining a spotlight on the women in science who are helping to lead these advances.
Through its significant investment in cancer research – more than $1.2 billion since its founding nearly 70 years ago – LLS is committed to funding and recognizing female scientists, physicians, social workers and nurses, and encouraging young women to participate in STEM (science, technology, engineering and math) education and pursue careers in the sciences.
To view the multimedia release go to:
https://www.multivu.com/players/English/8128552-lls-women-in-science/
For over 10 years we at Middle Passage Consulting have given small business owners options that allow them to increase their return on their investments and increase their revenue. We offer much more than bridge loans and merchant cash advances. Here we assist with term loans, venture capital, health financing, equipment loans, asset based funding, purchase order funding, commercial real estate funding. If it's business funding we can help!
https://www.youtube.com/watch?v=p27dqEAOoew
Nearly five dozen 2019 models meet stricter criteria to qualify for a 2019 TOP SAFETY PICK+ or TOP SAFETY PICK award from the Insurance Institute for Highway Safety. The 30 first-tier “plus” award winners earn the highest rating for passenger-side protection in a small overlap front crash and have good-rated available headlights, while the 27 winners of the second-tier award qualify with an acceptable or higher rating in the newest IIHS crash test and the nighttime headlight evaluation.
All 57 vehicles in this elite group earn good ratings in the Institute’s five other crashworthiness evaluations and have an available automatic emergency braking system that rates advanced or superior for front crash prevention.
IIHS now requires a good rating in the passenger-side small overlap front test to earn a 2019 TOP SAFETY PICK+ versus an acceptable or good rating for the 2018 award. An acceptable or good rating in the passenger-side test is a new criterion to earn a 2019 TOP SAFETY PICK.
This marks the sixth time that IIHS has raised the bar to earn the TOP SAFETY PICK+ award since introducing it in the 2013 model year to recognize vehicles that offer a superior level of safety. The TOP SAFETY PICK accolade launched in the 2006 model year to help consumers identify vehicles with the highest ratings. Over the years, IIHS has added to and strengthened criteria for both awards to encourage manufacturers to speed up safety advances.
